TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Life Genomics AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,576
|
2,701
|
4,116 |
| Financial expenses |
0
|
0
|
8 |
| Earnings before taxes |
-166
|
-466
|
-2,723 |
| EBITDA |
-171
|
-445
|
-2,212 |
| Total assets |
2,090
|
2,332
|
3,896 |
| Current assets |
2,019
|
2,222
|
3,748 |
| Current liabilities |
469
|
481
|
1,586 |
| Equity capital |
1,621
|
1,850
|
2,310 |
| - share capital |
39
|
41
|
41 |
| Employees (average) |
7
|
10
|
18 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
77.6%
|
79.3%
|
59.3% |
| Turnover per employee |
368
|
270
|
229 |
| Profit as a percentage of turnover |
-6.4%
|
-17.3%
|
-66.2% |
| Return on assets (ROA) |
-7.9%
|
-20.0%
|
-69.7% |
| Current ratio |
430.5%
|
462.0%
|
236.3% |
| Return on equity (ROE) |
-10.2%
|
-25.2%
|
-117.9% |
| Change turnover |
-33
|
-1,426
|
-6,920 |
| Change turnover % |
-1%
|
-35%
|
-63% |
| Chg. No. of employees |
-3
|
-8
|
-5 |
| Chg. No. of employees % |
-30%
|
-44%
|
-22% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.